Cancer Biology Training Consortium (EIN 260497269) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2007

Legal Domicile

Principal Officer

Sheridan L Ellis

Phone

5202228722

Tax Period

2025-01-01 to 2025-12-31

Cancer Biology Training Consortium, founded in 2007, is a small nonprofit in the Medical Research sector that reported $390K in total revenue in fiscal year 2025. Revenue grew 10% year-over-year, indicating healthy expansion. The organization ran a surplus of $147K, a strong 38% operating margin.

Mission

To help medical schools and research institutes exchange ideas on the best training outcomes for cancer research trainees

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $168,000

Program Service Revenue $220,555

Investment Income $1,832

Other Revenue $0

TOTAL REVENUE $390,387

Expense Breakdown

Grants Paid $0

Salaries & Benefits $27,935

Fundraising Expenses $0

Program Expenses $193,474

Other Expenses $215,945

TOTAL EXPENSES $243,880

Year-over-Year Comparison

	2025	2024	Change
Revenue	$390,387	$353,964	+0.1%
Expenses	$243,880	$265,191	-0.1%
Net Income	$146,507	$88,773	+0.7%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$25,000

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
SHERIDAN L ELLIS	Asst Sec Treas	17.00	Officer	$25,000	$0	$25,000
KATHLEEN O'CONNOR	Director	1.00	Director	$0	$0	$0
LALITA SAMANT	Director	1.00	Director	$0	$0	$0
LAWRENCE BOISE	Director	1.00	Director	$0	$0	$0
JANET V CROSS	PresidentElect Sec	1.00	Director	$0	$0	$0
KRISTIN A ECKERT	Director	1.00	Director	$0	$0	$0
JULIE RHOADES	Director	1.00	Director	$0	$0	$0
REBECCA RIGGINS	Director	0.00	Director	$0	$0	$0
PAUL GRIPPO	Director	1.00	Director	$0	$0	$0
RAJAGOPAL RAMESH	Director	1.00	Director	$0	$0	$0
ROLF A BREKKEN	President	0.00	Officer	$0	$0	$0
DANNY R WELCH	Treasurer VP	1.00	Officer	$0	$0	$0
HARIKRISHNA NAKSHATRI	President	2.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$390,387	$243,880	$364,821	$146,507
2024	$353,964	$265,191	$215,464	$88,773
2023	$370,410	$343,515	$126,691	$26,895
2022	$208,168	$235,886	$99,630	$-27,718

Cancer Biology Training Consortium